Company Overview and News

 
Top Analyst Upgrades and Downgrades: Alcoa, Apple, Amazon, Facebook, Kinder Morgan, Philip Morris, P&G, Twitter, Williams Companies and Many More

2018-04-20 247wallst
Stocks were indicated to open marginally lower on Friday morning, but that may be a lack of direction after close to a 2% gain this week in the Dow Jones industrial average and S&P 500. Some investors have been rethinking what the nine-year bull market may bring in 2018 and beyond. After all, the trend of buying pullbacks has become more vulnerable to sellers, volatility and each major news headline.
Upvote Downvote

 
Earnings Confirm Alcoa Corp Is in a Sweet Spot | InvestorPlace

2018-04-19 investorplace
Alcoa Corp (NYSE:AA) has posted its numbers, and the first-quarter earnings season is unofficially underway. And, if the company really is the tone-setter for earnings reports, we have good reason to be excited.the aluminum company topped its earnings expectations, and AA stock advanced 4% in response.
Upvote Downvote

 
Top Analyst Upgrades and Downgrades: Adtran, Alcoa, Clorox, Kinder Morgan, Lam Research, MGIC, Sprint, Walmart and More

2018-04-19 247wallst
Stocks have been gaining of late as earnings season kicks off, but the major equity indexes were indicated to open lower on Thursday. Investors have been rethinking what the nine-year bull market may bring in 2018 and beyond. The trend of buying pullbacks has become more vulnerable to sellers, volatility, and each major news headline versus in 2017. Many investors are finding it hard to decide how they want their assets positioned for the longer term.
Upvote Downvote

 
Western Digital, Bed Bath & Beyond and Alcoa highlighted as Zacks Bull and Bear of the Day

2018-04-19 zacks
Chicago, IL – April 19, 2018 – Zacks Equity Research highlights Western Digital Corporation (WDC - Free Report) as the Bull of the Day, Bed Bath & Beyond (BBBY - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Alcoa Corp. (AA - Free Report) .
Upvote Downvote

 
RPT-U.S. customers scramble to replace Rusal metal after sanctions

2018-04-19 reuters
NEW YORK, April 19 (Reuters) - U.S. customers of Rusal are scrambling to figure out how to replace supply from the Russian company after U.S. sanctions on the world’s second-largest aluminum producer caused prices to spike to a seven-year high, the companies and metals analysts said.
Upvote Downvote

 
U.S. stock futures search for a catalyst as earnings stay in focus - MarketWatch

2018-04-19 marketwatch
U.S. stock-index futures pointed to a roughly flat open Thursday, putting the main gauges on track for a second-straight day of muted action.
Upvote Downvote

 
Sanctions Fallout Upends Metals as Aluminum, Nickel Burst Higher - Bloomberg

2018-04-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Alcoa's (AA) CEO Roy Harvey on Q1 2018 Results - Earnings Call Transcript

2018-04-19 seekingalpha
Good afternoon, and welcome to the Alcoa Corporation First Quarter 2018 Earnings Presentation and Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
Upvote Downvote

 
U.S. customers scramble to replace Rusal metal after sanctions

2018-04-19 reuters
NEW YORK (Reuters) - U.S. customers of Rusal are scrambling to figure out how to replace supply from the Russian company after U.S. sanctions on the world’s second-largest aluminum producer caused prices to spike to a seven-year high, the companies and metals analysts said.
Upvote Downvote

 
Alcoa Corp (AA) Updates Guidance on Aluminum Supply Shortfall

2018-04-18 investorplace
Alcoa Corp (NYSE:AA) had a strong afternoon as the company increased its guidance and posted an earnings beat in its latest quarterly report.
Upvote Downvote

 
Alcoa (AA) Posts Earnings Beat, Raises Full-Year EBITDA Guidance

2018-04-18 zacks
Alcoa Corp. (AA - Free Report) just released its latest quarterly financial results, posting adjusted earnings of $0.77 per share and revenues of $3.09 billion.
Upvote Downvote

 
AA: Alcoa Corp - Stock Quote and News - CNBC

2018-04-18 cnbc
Like all ChartIQ markers, the object itself is managed by the chart, so when you scroll the chart the object moves with you. It is also destroyed automatically for you when the symbol is changed.
Upvote Downvote

 
Do Options Traders Know Something About Alcoa (AA) Stock We Don't?

2018-04-18 zacks
Investors in Alcoa Corporation (AA - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 20, 2018 $33.00 Put had some of the highest implied volatility of all equity options today.
Upvote Downvote

 
Aluminium price rallies

2018-04-18 thestar.com.my
SHANGHAI: Aluminium held near the highest in more than six years as the impact of US sanctions against Russia’s United Co Rusal dominated trading more than a week after they were announced, with buyers rushing to secure alternative supplies amid forecasts the price may hit US$3,000 a tonne.
Upvote Downvote

 
Aluminum Sanctions Convulse Market as Rally to $3,000 Forecast - Bloomberg

2018-04-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...